4.2 Letter

Combined Central and Peripheral Demyelination with Anti-Neurofascin155 IgG Following COVID-19 Vaccination

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Marie Scully et al.

Summary: 23 cases of thrombotic thrombocytopenia were reported after receiving the AstraZeneca vaccine, incited by antibodies to platelet factor 4 and unrelated to heparin therapy. Avoidance of platelet transfusion and consideration of nonheparin anticoagulant and intravenous immune globulin are recommended for treatment.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Clinical Neurology

Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy

Luise Appeltshauser et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Biochemistry & Molecular Biology

Anti-neurofascin autoantibody and demyelination

Jun-ichi Kira et al.

NEUROCHEMISTRY INTERNATIONAL (2019)

Article Clinical Neurology

Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment

A. Cortese et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)